Reportlinker Adds South Africa In Vitro Diagnostics Market Outlook to 2016

NEW YORK, July 22 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

South Africa In Vitro Diagnostics Market Outlook to 2016

http://www.reportlinker.com/p0240270/South-Africa-In-Vitro-Diagnostics-Market-Outlook-to-2016.html

South Africa In Vitro Diagnostics Market Outlook to 2016

Summary

GlobalData's new report, "South Africa In Vitro Diagnostics Market Outlook to 2016" provides key market data on the South Africa In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.

- 2009 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the South Africa In Vitro Diagnostics (IVD) market.

- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the South Africa In Vitro Diagnostics (IVD) competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 11

2 Introduction 14

2.1 What is This Report About? 14

3 In Vitro Diagnostics In South Africa 15

3.1 In Vitro Diagnostics, Market Segmentation 15

3.2 In Vitro Diagnostics, South Africa, Overall Revenue ($m), 2002-2016 16

3.3 In Vitro Diagnostics Market, South Africa, Revenue Mix ($m), 2009 18

3.4 In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2009 19

3.5 In Vitro Diagnostics, South Africa, Company Share (2008-2009) 25

4 Clinical Chemistry In South Africa 27

4.1 Clinical Chemistry, Market Segmentation 27

4.2 Clinical Chemistry Market, South Africa, Revenue Mix ($m), 2009 28

4.3 Clinical Chemistry Market, South Africa, Category Contribution (%), 2009 29

4.4 Clinical Chemistry Overall Revenue (2002-2016) 30

4.4.1 Clinical Chemistry Analyzers Revenue (2002-2016) 34

4.4.2 Urine Analysis Revenue (2002-2016) 38

4.5 Clinical Chemistry Distribution Share (2008-2009) 42

4.6 Clinical Chemistry, South Africa, Company Share (2008-2009) 43

5 Genetic Testing In South Africa 45

5.1 Genetic Testing, Market Segmentation 45

5.2 Genetic Testing Market, South Africa, Revenue Mix ($m), 2009 46

5.3 Genetic Testing Market, South Africa, Category Contribution (%), 2009 47

5.4 Genetic Testing Overall Revenue (2002-2016) 48

5.5 Genetic Testing Distribution Share (2008-2009) 52

5.6 Genetic Testing, South Africa, Company Share (2008-2009) 53

6 Haematology In South Africa 55

6.1 Haematology, Market Segmentation 55

6.2 Haematology Market, South Africa, Revenue Mix ($m), 2009 56

6.3 Haematology Market, South Africa, Category Contribution (%), 2009 57

6.4 Haematology Overall Revenue (2002-2016) 58

6.4.1 Haematology Reagents Revenue (2002-2016) 62

6.4.2 Immunohaematology Revenue (2002-2016) 66

6.4.3 Haemostasis Revenue (2002-2016) 70

6.4.4 Haematology Rapid Tests Revenue (2002-2016) 74

6.4.5 Haematology Cell Counters Revenue (2002-2016) 78

6.5 Haematology Distribution Share (2008-2009) 82

6.6 Haematology, South Africa, Company Share (2008-2009) 83

7 Histology And Cytology In South Africa 85

7.1 Histology and Cytology, Market Segmentation 85

7.2 Histology and Cytology Market, South Africa, Revenue Mix ($m), 2009 86

7.3 Histology and Cytology Market, South Africa, Category Contribution (%), 2009 87

7.4 Histology And Cytology Overall Revenue (2002-2016) 88

7.4.1 Histology Revenue (2002-2016) 92

7.5 Histology And Cytology Distribution Share (2008-2009) 96

7.6 Histology And Cytology, South Africa, Company Share (2008-2009) 97

8 Immuno Chemistry In South Africa 99

8.1 Immuno Chemistry, Market Segmentation 99

8.2 Immuno Chemistry Market, South Africa, Revenue Mix ($m), 2009 100

8.3 Immuno Chemistry Market, South Africa, Category Contribution (%), 2009 101

8.4 Immuno Chemistry Overall Revenue (2002-2016) 102

8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 106

8.4.2 Drug Related Testing Revenue (2002-2016) 110

8.4.3 Endocrinology Tests Revenue (2002-2016) 114

8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 118

8.5 Immuno Chemistry Distribution Share (2008-2009) 122

8.6 Immuno Chemistry, South Africa, Company Share (2008-2009) 123

9 Infectious Immunology In South Africa 125

9.1 Infectious Immunology, Market Segmentation 125

9.2 Infectious Immunology Market, South Africa, Revenue Mix ($m), 2009 126

9.3 Infectious Immunology Market, South Africa, Category Contribution (%), 2009 127

9.4 Infectious Immunology Overall Revenue (2002-2016) 128

9.5 Infectious Immunology Distribution Share (2008-2009) 132

9.6 Infectious Immunology, South Africa, Company Share (2008-2009) 133

10 Microbiology Culture In South Africa 135

10.1 Microbiology Culture, Market Segmentation 135

10.2 Microbiology Culture Market, South Africa, Revenue Mix ($m), 2009 136

10.3 Microbiology Culture Market, South Africa, Category Contribution (%), 2009 137

10.4 Microbiology Culture Overall Revenue (2002-2016) 138

10.4.1 Microbiology Analyzers Revenue (2002-2016) 142

10.5 Microbiology Culture Distribution Share (2008-2009) 146

10.6 Microbiology Culture, South Africa, Company Share (2008-2009) 147

11 Overview of Key Companies in South Africa In Vitro Diagnostics Market 148

11.1 F. Hoffmann-La Roche Ltd. 148

11.1.1 Company Overview 148

11.1.2 Share in the South Africa In Vitro Diagnostics Market 148

11.2 Abbott Laboratories 149

11.2.1 Company Overview 149

11.2.2 Share in the South Africa In Vitro Diagnostics Market 149

11.3 bioMerieux S.A. 150

11.3.1 Company Overview 150

11.3.2 Share in the South Africa In Vitro Diagnostics Market 150

11.4 Ortho-Clinical Diagnostics Inc. 151

11.4.1 Company Overview 151

11.4.2 Share in the South Africa In Vitro Diagnostics Market 151

11.5 Siemens Healthcare 152

11.5.1 Company Overview 152

11.5.2 Share in the South Africa In Vitro Diagnostics Market 152

11.6 Beckman Coulter, Inc. 153

11.6.1 Company Overview 153

11.6.2 Share in the South Africa In Vitro Diagnostics Market 153

11.7 Inverness Medical Innovations, Inc. 154

11.7.1 Company Overview 154

11.8 Becton, Dickinson and Company 154

11.8.1 Company Overview 154

11.9 Bio-Rad Laboratories, Inc. 155

11.9.1 Company Overview 155

11.10 Hologic, Inc. 155

11.10.1 Company Overview 155

11.11 OLYMPUS CORPORATION 156

11.11.1 Company Overview 156

11.12 Mindray Medical International Limited 156

11.12.1 Company Overview 156

11.13 Sysmex Corporation 157

11.13.1 Company Overview 157

11.14 DiaSorin S.p.A. 157

11.14.1 Company Overview 157

11.15 Qiagen N.V. 157

11.15.1 Company Overview 157

11.16 Gen-Probe Incorporated 158

11.16.1 Company Overview 158

11.17 Phadia AB 158

11.17.1 Company Overview 158

11.18 Makromed Manufacturing (Pty) Ltd 158

11.18.1 Company Overview 158

12 In Vitro Diagnostics Market Pipeline Products 159

12.1 Clinical Chemistry Market Pipeline Products 159

12.2 Immuno Chemistry Market Pipeline Products 161

12.3 Haematology Market Pipeline Products 162

12.4 Infectious Immunology Market Pipeline Products 163

12.5 Microbiology Culture Market Pipeline Products 165

12.6 Histology and Cytology Market Pipeline Products 166

12.7 Genetic Testing Market Pipeline Products 167

13 Financial Deals Landscape 169

13.1 Partnerships 169

13.1.1 QIAGEN Enters Into Distribution Agreement With Celera 169

13.1.2 Sequenom Enters Into Licensing Agreement With Optherion 170

13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 171

13.1.4 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 172

13.1.5 HairDX Enters Into Distribution Agreement With HairOptions 173

13.1.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 174

14 Recent Developments 175

14.1 Product News 175

14.1.1 Jan 11, 2010: HairDX Forms Alliance For Distribution Of HairDX Genetic Test In South Africa 175

15 Appendix 176

15.1 Definitions of Markets Covered in the Report 177

15.1.1 In Vitro Diagnostics 177

15.2 Research Methodology 185

15.3 Secondary Research 186

15.4 Primary Research 186

15.5 Models 187

15.6 Forecasts 187

15.7 Expert Panels 187

15.8 GlobalData Consulting 187

15.9 Currency Conversion 188

15.10 Contact Us 188

15.11 Disclaimer 188

1.1 List of Tables

Table 1: In Vitro Diagnostics, South Africa, Overall Revenue ($m), 2002-2016 17

Table 2: In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2009 19

Table 3: In Vitro Diagnostics, South Africa, Cross-Category Analysis, 2002-2016 20

Table 4: In Vitro Diagnostics, South Africa, Overall Revenue ($m), Historic, 2002-2009 22

Table 5: In Vitro Diagnostics, South Africa, Overall Revenue ($m), Forecast, 2009-2016 24

Table 6: In Vitro Diagnostics, South Africa, Company Share by Revenue ($m), 2008-2009 26

Table 7: Clinical Chemistry Market, South Africa, Category Contribution (%), 2009 29

Table 8: Clinical Chemistry, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 31

Table 9: Clinical Chemistry, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 33

Table 10: Clinical Chemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35

Table 11: Clinical Chemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37

Table 12: Urine Analysis, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39

Table 13: Urine Analysis, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41

Table 14: Clinical Chemistry, South Africa, Distribution Share by Revenue ($m), 2008-2009 42

Table 15: Clinical Chemistry, South Africa, Company Share by Revenue ($m), 2008-2009 44

Table 16: Genetic Testing Market, South Africa, Category Contribution (%), 2009 47

Table 17: Genetic Testing, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 49

Table 18: Genetic Testing, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 51

Table 19: Genetic Testing, South Africa, Distribution Share by Revenue ($m), 2008-2009 52

Table 20: Genetic Testing, South Africa, Company Share by Revenue ($m), 2008-2009 54

Table 21: Haematology Market, South Africa, Category Contribution (%), 2009 57

Table 22: Haematology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 59

Table 23: Haematology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 61

Table 24: Haematology Reagents, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63

Table 25: Haematology Reagents, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 65

Table 26: Immunohaematology, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 67

Table 27: Immunohaematology, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 69

Table 28: Haemostasis, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71

Table 29: Haemostasis, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73

Table 30: Haematology Rapid Tests, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 75

Table 31: Haematology Rapid Tests, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 77

Table 32: Haematology Cell Counters, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 79

Table 33: Haematology Cell Counters, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81

Table 34: Haematology, South Africa, Distribution Share by Revenue ($m), 2008-2009 82

Table 35: Haematology, South Africa, Company Share by Revenue ($m), 2008-2009 84

Table 36: Histology and Cytology Market, South Africa, Category Contribution (%), 2009 87

Table 37: Histology And Cytology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 89

Table 38: Histology And Cytology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 91

Table 39: Histology, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 93

Table 40: Histology, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 95

Table 41: Histology And Cytology, South Africa, Distribution Share by Revenue ($m), 2008-2009 96

Table 42: Histology And Cytology, South Africa, Company Share by Revenue ($m), 2008-2009 98

Table 43: Immuno Chemistry Market, South Africa, Category Contribution (%), 2009 101

Table 44: Immuno Chemistry, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 103

Table 45: Immuno Chemistry, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 105

Table 46: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 107

Table 47: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 109

Table 48: Drug Related Testing, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 111

Table 49: Drug Related Testing, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 113

Table 50: Endocrinology Tests, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 115

Table 51: Endocrinology Tests, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 117

Table 52: Immunochemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 119

Table 53: Immunochemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 121

Table 54: Immuno Chemistry, South Africa, Distribution Share by Revenue ($m), 2008-2009 122

Table 55: Immuno Chemistry, South Africa, Company Share by Revenue ($m), 2008-2009 124

Table 56: Infectious Immunology Market, South Africa, Category Contribution (%), 2009 127

Table 57: Infectious Immunology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 129

Table 58: Infectious Immunology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 131

Table 59: Infectious Immunology, South Africa, Distribution Share by Revenue ($m), 2008-2009 132

Table 60: Infectious Immunology, South Africa, Company Share by Revenue ($m), 2008-2009 134

Table 61: Microbiology Culture Market, South Africa, Category Contribution (%), 2009 137

Table 62: Microbiology Culture, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 139

Table 63: Microbiology Culture, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 141

Table 64: Microbiology Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 143

Table 65: Microbiology Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 145

Table 66: Microbiology Culture, South Africa, Distribution Share by Revenue ($m), 2008-2009 146

Table 67: Microbiology Culture, South Africa, Company Share by Revenue ($m), 2008-2009 147

Table 68: Clinical Chemistry Market Pipeline Products 159

Table 69: Immuno Chemistry Market Pipeline Products 161

Table 70: Haematology Market Pipeline Products 162

Table 71: Infectious Immunology Market Pipeline Products 163

Table 72: Microbiology Culture Market Pipeline Products 165

Table 73: Histology and Cytology Market Pipeline Products 166

Table 74: Genetic Testing Market Pipeline Products 167

Table 75: QIAGEN Enters Into Distribution Agreement With Celera 169

Table 76: Sequenom Enters Into Licensing Agreement With Optherion 170

Table 77: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 171

Table 78: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 172

Table 79: HairDX Enters Into Distribution Agreement With HairOptions 173

Table 80: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 174

Table 81: USD to Local Currency, South Africa, Average Actual Rate 2002-2009 188

1.2 List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 15

Figure 2: In Vitro Diagnostics, South Africa, Overall Revenue ($m), 2002-2016 16

Figure 3: In Vitro Diagnostics Market, South Africa, Revenue Mix ($m), 2009 18

Figure 4: In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2009 19

Figure 5: In Vitro Diagnostics, South Africa, Cross-Category Analysis, 2002-2016 20

Figure 6: In Vitro Diagnostics, South Africa, Overall Revenue ($m), Historic, 2002-2009 21

Figure 7: In Vitro Diagnostics, South Africa, Overall Revenue ($m), Forecast, 2009-2016 23

Figure 8: In Vitro Diagnostics, South Africa, Company Share (%), 2009 25

Figure 9: Clinical Chemistry, Market Segmentation 27

Figure 10: Clinical Chemistry Market, South Africa, Revenue Mix ($m), 2009 28

Figure 11: Clinical Chemistry Market, South Africa, Category Contribution (%), 2009 29

Figure 12: Clinical Chemistry, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 30

Figure 13: Clinical Chemistry, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 32

Figure 14: Clinical Chemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 34

Figure 15: Clinical Chemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 36

Figure 16: Urine Analysis, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38

Figure 17: Urine Analysis, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40

Figure 18: Clinical Chemistry, South Africa, Company Share (%), 2009 43

Figure 19: Genetic Testing, Market Segmentation 45

Figure 20: Genetic Testing Market, South Africa, Revenue Mix ($m), 2009 46

Figure 21: Genetic Testing Market, South Africa, Category Contribution (%), 2009 47

Figure 22: Genetic Testing, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 48

Figure 23: Genetic Testing, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 50

Figure 24: Genetic Testing, South Africa, Company Share (%), 2009 53

Figure 25: Haematology, Market Segmentation 55

Figure 26: Haematology Market, South Africa, Revenue Mix ($m), 2009 56

Figure 27: Haematology Market, South Africa, Category Contribution (%), 2009 57

Figure 28: Haematology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 58

Figure 29: Haematology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 60

Figure 30: Haematology Reagents, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62

Figure 31: Haematology Reagents, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64

Figure 32: Immunohaematology, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66

Figure 33: Immunohaematology, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68

Figure 34: Haemostasis, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70

Figure 35: Haemostasis, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72

Figure 36: Haematology Rapid Tests, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74

Figure 37: Haematology Rapid Tests, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 76

Figure 38: Haematology Cell Counters, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78

Figure 39: Haematology Cell Counters, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80

Figure 40: Haematology, South Africa, Company Share (%), 2009 83

Figure 41: Histology and Cytology, Market Segmentation 85

Figure 42: Histology and Cytology Market, South Africa, Revenue Mix ($m), 2009 86

Figure 43: Histology and Cytology Market, South Africa, Category Contribution (%), 2009 87

Figure 44: Histology And Cytology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 88

Figure 45: Histology And Cytology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 90

Figure 46: Histology, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 92

Figure 47: Histology, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 94

Figure 48: Histology And Cytology, South Africa, Company Share (%), 2009 97

Figure 49: Immuno Chemistry, Market Segmentation 99

Figure 50: Immuno Chemistry Market, South Africa, Revenue Mix ($m), 2009 100

Figure 51: Immuno Chemistry Market, South Africa, Category Contribution (%), 2009 101

Figure 52: Immuno Chemistry, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 102

Figure 53: Immuno Chemistry, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 104

Figure 54: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106

Figure 55: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108

Figure 56: Drug Related Testing, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 110

Figure 57: Drug Related Testing, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 112

Figure 58: Endocrinology Tests, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 114

Figure 59: Endocrinology Tests, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 116

Figure 60: Immunochemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 118

Figure 61: Immunochemistry Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 120

Figure 62: Immuno Chemistry, South Africa, Company Share (%), 2009 123

Figure 63: Infectious Immunology, Market Segmentation 125

Figure 64: Infectious Immunology Market, South Africa, Revenue Mix ($m), 2009 126

Figure 65: Infectious Immunology Market, South Africa, Category Contribution (%), 2009 127

Figure 66: Infectious Immunology, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 128

Figure 67: Infectious Immunology, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 130

Figure 68: Infectious Immunology, South Africa, Company Share (%), 2009 133

Figure 69: Microbiology Culture, Market Segmentation 135

Figure 70: Microbiology Culture Market, South Africa, Revenue Mix ($m), 2009 136

Figure 71: Microbiology Culture Market, South Africa, Category Contribution (%), 2009 137

Figure 72: Microbiology Culture, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 138

Figure 73: Microbiology Culture, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 140

Figure 74: Microbiology Analyzers, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 142

Figure 75: Microbiology Analyzers, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 144

Figure 76: Microbiology Culture, South Africa, Company Share (%), 2009 147

Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),South Africa In Vitro Diagnostics Market, 2009 148

Figure 78: Abbott Laboratories, Company Share (%),South Africa In Vitro Diagnostics Market, 2009 149

Figure 79: bioMerieux S.A., Company Share (%),South Africa In Vitro Diagnostics Market, 2009 150

Figure 80: Ortho-Clinical Diagnostics Inc., Company Share (%),South Africa In Vitro Diagnostics Market, 2009 151

Figure 81: Siemens Healthcare, Company Share (%),South Africa In Vitro Diagnostics Market, 2009 152

Figure 82: Beckman Coulter, Inc., Company Share (%),South Africa In Vitro Diagnostics Market, 2009 153

Figure 83: GlobalData Methodology 185

Companies mentioned

F. Hoffmann-La Roche Ltd.

Abbott Laboratories

bioMerieux S.A.

Ortho-Clinical Diagnostics Inc.

Siemens Healthcare

Beckman Coulter, Inc.

Inverness Medical Innovations, Inc.

Becton, Dickinson and Company

Bio-Rad Laboratories, Inc.

Hologic, Inc.

OLYMPUS CORPORATION

Mindray Medical International Limited

Sysmex Corporation

DiaSorin S.p.A.

Qiagen N.V.

Gen-Probe Incorporated

Phadia AB

Makromed Manufacturing (Pty) Ltd

To order this report:

In Vitro Diagnostic Industry: South Africa In Vitro Diagnostics Market Outlook to 2016

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker

21%

more press release views with 

Request a Demo